Update in pulmonary arterial hypertension 2007

This article summarizes recent advances in the field of pulmonary arterial hypertension (PAH), a severe condition characterized by a progressive remodeling of small pulmonary arteries leading to elevated pulmonary vascular resistance and right ventricular failure (1, 2). Epidemiology, genetics, pathophysiology, and treatment will be the main focus of this update.